Pharmaceutical Risk Management: Practical Applications

Looming EU GDPR Requirements: What Life Sciences Companies Must Do to Ensure Compliance

Payor Interactions: Emerging Risks and Compliance Considerations

Corporate & Commercial 101 - Business Development Briefing: What you need to know when working on corporate and commercial transactions

21st Century Cures Act: What Life Sciences Companies Need To Know

Compliance with Final PAMA Rules - Advanced Diagnostic Laboratory Tests: What Considerations for Launching a New Test?

Compliance with Final PAMA Rules - Private Payor Data Reporting: What Information Must Be Reported, When, and How?

Compliance with Final PAMA Rules - Applicable Laboratories: Is Your Lab Required to Report?

How Effective Is Your Compliance Program?

Pharmaceutical and Medical Device Enforcement and Investigations Forum

Staying Ahead of the Curve: Managing Advertising and Data Privacy and Security Issues Raised by Consumer-Directed Mobile Apps and Health IT

Olympus’ $640 Million Fraud & Abuse and FCPA Settlement: What It Means for Your Global Compliance Program

Hot Global Compliance Topics in the Pharmaceutical and Medical Device Sectors: Controlling Evolving Risks

Arnold & Porter's Life Sciences Legal Update Conference

Pharmaceutical and Medical Device Compliance Update: Management of Critical and Emerging Legal Challenges

Advertising and Promotion Update - Drugs, Devices and Combination Products

Are You Ready?: Preparing for a New Joint Venture, Partnership, or Sale Transaction

Finding the Right Partner and Model: Joint Ventures, Integration, and Outsourcing Strategies to Meet Today's Healthcare Payment and Delivery Challenges

New Payment Rate Reporting Requirements for Clinical Laboratories: Are You Prepared?

How is Medicare Adapting to the mHealth and Emerging Technologies Revolution?

It's Getting Hot in Here: Sunshine Act Reporting Trends, Enforcement, and Best Practices

Getting Your House in Order: Key Compliance and Corporate Issues that Diminish Value or Kill the Deal

Connecting Through mHealth Solutions: Fraud & Abuse Implications for Patient, Physician, ACO, Hospital and Industry Partner Engagement Models

Physician Compensation in the 21st Century / Demand for Medical Technology

Physician Compensation in the 21st Century / Physician Leadership

Medicare's New Physician Payment System: What's Now, and What's Next

Arnold & Porter US and EU Drug and Device Enforcement Boot Camp

Understanding NICE and Health Technology Appraisals

Beyond Product Launch: Navigating FDA Post-Market Requirements for mHealth and Health IT

Use of Investigative Resources and Assertion of Victim Rights To Support Brand Protection

FCPA Boot Camp

Drug Supply Chain Security Act (DSCSA): How To Get Ready (Fast) for Track & Trace

Emerging Issues in FDA Law: Implementation of DQSA

FDA Medical Device Law Fundamentals

Arnold & Porter's Life Sciences Legal Update Day

European Compliance Update

Hospital Qui Tam Symposium: Preventing Whistleblower Suits Through the Coordination of Employment and False Claims Counsel

Trends and Hot Topics Concerning Pharmaceutical Industry Risk Enforcement

European Life Sciences Legal Update Day

Breakthrough or More of the Same? New Pathways and Exclusivities in FDA Approval Processes

The FDA's Upcoming Trans Fat Ban: Prelude to More Food Industry Litigation?

Upcoming CLE Course: Critical Issues in Pharmaceutical Promotion and Medical Affairs Activities

Upcoming CLE Course: Enforcement Trends Update

Emerging Issues in Food and Drug Law: Implementation of FDASIA

Developments in the 340B Program - Legal and Strategic Perspectives on Program Integrity, Manufacturer Audits, and the Determination of "Reasonable Cause" for an Audit

Good Day, Sunshine: Key Components and Implications of the Final Rule Implementing the Physician Payment Sunshine Act

IP/Technology 2013 Update: Trademark, Copyright, Trade Secret, and Unfair Competition Program

IP/Technology 2013 Update: Patent Law Program

Hot Topics for Drug Manufacturers: Orphan Drugs, FDASIA, Clinical Studies, and Warning Letter Trends

Emergency ACO Summit: Analyzing the Final Rule

Current Issues in the Cosmetics Sector and Future Trends

The Arnold & Porter Knowledge Leader Series: Pharmaceuticals: Key Trends and Regulatory Developments in 2010-The Prospects for 2011

WEBCAST: Marketing Medical and Consumer Products in Social Media

Government Investigations for Life Sciences

Protecting Your Medical Products Supply Chain: A Webinar on Preventing and Addressing Cargo/Warehouse Theft

Strategies for Successful Hospital-Physician Alignment: What Physicians and Hospitals Need to Know

False Claims Act and Anti-Kickback Statute Enforcement on Performance Based Contracts in the Pharmaceutical and Device Industries

Brand Integrity, Security, and Anti-Counterfeiting for the Pharmaceutical Industry How to Deal With the Bad Guys and Work with the Feds

American Conference Institute's FDA Enforcement Summit

New York Society for Health Planning presents UPDATE - New York State/Federal Payment Recovery Agenda Understanding and Successfully Navigating the Risks

BIO International Convention - Impact on Policy in Biobusiness

BIO International Convention - Legal/Intellectual Property

Health Care 2010: Managing Risks in the New Compliance and Enforcement Environment

8th Corporate Counsel Expert Guide to Advertising, eMarketing & Promotions for the Pharmaceutical Industry

FDA Boot Camp

Introduction and Overview: Challenges for the Pharmaceutical Industry in Internet and Social Marketing Activities

Conference on 5th Annual Biosimilars (Conference and Workshop)

The International Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum

Drug and Medical Device Seminar

The Food, Drug and Cosmetic Act: Searching for the Crossroads of Safety and Innovation

Nuts and Bolts of Sustaining Programs Through Mergers & Collaborations

First Annual Summit on Disclosure, Transparency and Aggregate Spend for Drug, Device and Biotech Companies

PODCAST: Medical Practice Trends Podcast 5: Washington Update: Relationships between MDs and Pharma Scrutinized

ECRI Institute's 16th Annual Conference on Using Evidence in Policy and in Practice

American Conference Institute's 7th Annual Corporate Counsel Forum on Advertising & Promotions for the Pharmaceutical Industry

10th Annual Medicaid Rebates

Legal & Regulatory Conference 2008

AdvaMed 2008 Annual Meeting

4th Annual In-House Counsel Forum on Pharmaceutical Antitrust

12th Annual Drug & Medical Device Litigation, 2007

The Eighth Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum

3rd Biennial Federal Drug Pricing Program: Confronting the Complexities of Federal Drug Pricing: 15 Years of the Veterans Health Care Act

CLE: The FDA Amendments Act: Overview and Implications for Pharmaceutical Manufacturers

AdvaMed 2007

Biosimilars 2007

Medical Device Pricing & Reimbursement

Bio International Convention

Healthcare on the Hill

Registries and Post-Marketing Data Collection